419 related articles for article (PubMed ID: 10190894)
1. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel RP
J Exp Med; 1999 Apr; 189(7):1033-42. PubMed ID: 10190894
[TBL] [Abstract][Full Text] [Related]
2. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy.
Steinman L
J Exp Med; 1999 Apr; 189(7):1021-4. PubMed ID: 10190892
[No Abstract] [Full Text] [Related]
3. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
Yu M; Johnson JM; Tuohy VK
J Exp Med; 1996 Apr; 183(4):1777-88. PubMed ID: 8666934
[TBL] [Abstract][Full Text] [Related]
4. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
Yu M; Johnson JM; Tuohy VK
J Neurosci Res; 1996 Aug; 45(4):463-70. PubMed ID: 8872907
[TBL] [Abstract][Full Text] [Related]
5. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
[TBL] [Abstract][Full Text] [Related]
6. Functional evidence for epitope spreading in the relapsing pathology of experimental autoimmune encephalomyelitis.
McRae BL; Vanderlugt CL; Dal Canto MC; Miller SD
J Exp Med; 1995 Jul; 182(1):75-85. PubMed ID: 7540658
[TBL] [Abstract][Full Text] [Related]
7. The epitope spreading cascade during progression of experimental autoimmune encephalomyelitis and multiple sclerosis.
Tuohy VK; Yu M; Yin L; Kawczak JA; Johnson JM; Mathisen PM; Weinstock-Guttman B; Kinkel RP
Immunol Rev; 1998 Aug; 164():93-100. PubMed ID: 9795767
[TBL] [Abstract][Full Text] [Related]
8. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
Takács K; Chandler P; Altmann DM
Eur J Immunol; 1997 Nov; 27(11):2927-34. PubMed ID: 9394820
[TBL] [Abstract][Full Text] [Related]
9. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
[TBL] [Abstract][Full Text] [Related]
10. Experimental autoimmune encephalomyelitis.
Rao P; Segal BM
Methods Mol Med; 2004; 102():363-75. PubMed ID: 15286395
[TBL] [Abstract][Full Text] [Related]
11. Functional role of epitope spreading in the chronic pathogenesis of autoimmune and virus-induced demyelinating diseases.
Miller SD; Eagar TN
Adv Exp Med Biol; 2001; 490():99-107. PubMed ID: 11505979
[TBL] [Abstract][Full Text] [Related]
12. Induction of a multiple sclerosis-like disease in mice with an immunodominant epitope of myelin oligodendrocyte glycoprotein.
Slavin A; Ewing C; Liu J; Ichikawa M; Slavin J; Bernard CC
Autoimmunity; 1998; 28(2):109-20. PubMed ID: 9771980
[TBL] [Abstract][Full Text] [Related]
13. Endogenous presentation of self myelin epitopes by CNS-resident APCs in Theiler's virus-infected mice.
Katz-Levy Y; Neville KL; Girvin AM; Vanderlugt CL; Pope JG; Tan LJ; Miller SD
J Clin Invest; 1999 Sep; 104(5):599-610. PubMed ID: 10487774
[TBL] [Abstract][Full Text] [Related]
14. A structurally available encephalitogenic epitope of myelin oligodendrocyte glycoprotein specifically induces a diversified pathogenic autoimmune response.
Bischof F; Bins A; Dürr M; Zevering Y; Melms A; Kruisbeek AM
J Immunol; 2004 Jul; 173(1):600-6. PubMed ID: 15210822
[TBL] [Abstract][Full Text] [Related]
15. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
Tuohy VK; Yu M; Yin L; Mathisen PM; Johnson JM; Kawczak JA
J Neuroimmunol; 2000 Nov; 111(1-2):55-63. PubMed ID: 11063821
[TBL] [Abstract][Full Text] [Related]
16. Analysis of autoreactive CD4 T cells in experimental autoimmune encephalomyelitis after primary and secondary challenge using MHC class II tetramers.
Bischof F; Hofmann M; Schumacher TN; Vyth-Dreese FA; Weissert R; Schild H; Kruisbeek AM; Melms A
J Immunol; 2004 Mar; 172(5):2878-84. PubMed ID: 14978089
[TBL] [Abstract][Full Text] [Related]
17. Role of pathogenic T cells and autoantibodies in relapse and progression of myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in LEW.1AV1 rats.
Matsumoto Y; Park IK; Hiraki K; Ohtani S; Kohyama K
Immunology; 2009 Sep; 128(1 Suppl):e250-61. PubMed ID: 19175799
[TBL] [Abstract][Full Text] [Related]
18. Experimental autoimmune encephalomyelitis in the rat.
Mannie M; Swanborg RH; Stepaniak JA
Curr Protoc Immunol; 2009 Apr; Chapter 15():15.2.1-15.2.15. PubMed ID: 19347844
[TBL] [Abstract][Full Text] [Related]
19. Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein.
McRae BL; Kennedy MK; Tan LJ; Dal Canto MC; Picha KS; Miller SD
J Neuroimmunol; 1992 Jun; 38(3):229-40. PubMed ID: 1376328
[TBL] [Abstract][Full Text] [Related]
20. Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells.
Pöllinger B; Krishnamoorthy G; Berer K; Lassmann H; Bösl MR; Dunn R; Domingues HS; Holz A; Kurschus FC; Wekerle H
J Exp Med; 2009 Jun; 206(6):1303-16. PubMed ID: 19487416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
